Meningococcal polysaccharide group A - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
NIMENRIX meningococcal (Groups A, C, W-135, Y) polysaccharide tetanus toxoid conjugate vaccine injection vial and diluent syringe AUST R: 199742Active ingredients:
Meningococcal polysaccharide group A
Meningococcal polysaccharide group C
Meningococcal polysaccharide group W135
Meningococcal polysaccharide Group Y
Tetanus toxoid
Dosage form:
Injection, powder for
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800 675 229
|
From
08 Jun 2026
to
26 Jun 2026
|
Shortage status:
Current
Availability:
Only available under NIP or government programs
Reason:
Manufacturing
Management action:
The sponsor is working to expedite the next shipment and is closely controlling supply. Alternative brands are available.
|